Bellevue Life Sciences Ac... (BLAC)

3.01

-3.72 (-55.27%)

At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	403.78K	-35.39K	-3.31K	-23.81K
Depreciation & Amortization	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a
Other Working Capital	517.35K	31.15K	2.85K	n/a
Other Non-Cash Items	-2.78M	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	1.55M	31.15K	2.85K	n/a
Operating Cash Flow	-818.77K	-4.24K	-461	-23.81K
Capital Expenditures	-4	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	-33.83M	n/a	n/a	n/a
Investing Cash Flow	-33.83M	n/a	n/a	n/a
Debt Repayment	-1.2M	800K	100K	n/a
Common Stock Repurchased	-36M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.77M	-676.02K	10K	86.47K
Financial Cash Flow	34.54M	123.98K	-57.44K	86.47K
Net Cash Flow	-109.08K	119.74K	-57.9K	62.65K
Free Cash Flow	-818.77K	-4.24K	-461	-23.81K